The Dephosphorylation of p70S6 (Thr389) Kinase as a Marker of l-Glutamate-Induced Excitotoxicity Related to Diabetes Disturbances—an Unconventional In Vitro Model
暂无分享,去创建一个
[1] E. Hascup,et al. Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression , 2019, ASN neuro.
[2] S. A. Wijtenburg,et al. Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia , 2019, Schizophrenia Research.
[3] F. Chen,et al. Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo , 2019, Front. Aging Neurosci..
[4] Yan Zeng,et al. Role of mTOR signaling in the regulation of high glucose-induced podocyte injury , 2019, Experimental and therapeutic medicine.
[5] S. Bolkent,et al. Tub and β-catenin play a key role in insulin and leptin resistance-induced pancreatic beta-cell differentiation. , 2018, Biochimica et biophysica acta. Molecular cell research.
[6] Jinzi Wu,et al. Humanin Attenuates NMDA-Induced Excitotoxicity by Inhibiting ROS-dependent JNK/p38 MAPK Pathway , 2018, International journal of molecular sciences.
[7] Karl W Barber,et al. PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling , 2018, Proceedings of the National Academy of Sciences.
[8] Claudio Aguayo,et al. Association between insulin resistance and the development of cardiovascular disease , 2018, Cardiovascular Diabetology.
[9] J. Zierath,et al. Skeletal Muscle Insulin Sensitivity Show Circadian Rhythmicity Which Is Independent of Exercise Training Status , 2018, Front. Physiol..
[10] P. Agarwal,et al. Hyper‐insulinemia increases the glutamate‐excitotoxicity in cortical neurons: A mechanistic study , 2018, European journal of pharmacology.
[11] Nikos Koundouros,et al. Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer , 2018, Front. Oncol..
[12] L. Buée,et al. Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies? , 2018, Neuroendocrinology.
[13] G. Castoria,et al. Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications , 2018, Front. Oncol..
[14] T. Chan,et al. Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] T. Dada. Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4? , 2017, Journal of current glaucoma practice.
[16] Shi-Yong Sun,et al. Inhibition of p70S6K does not mimic the enhancement of Akt phosphorylation by rapamycin , 2017, Heliyon.
[17] Shang-Der Chen,et al. Roles of p62 in BDNF‐dependent autophagy suppression and neuroprotection against mitochondrial dysfunction in rat cortical neurons , 2017, Journal of neurochemistry.
[18] Zhuo-wei Hu,et al. The regulation of β-catenin activity and function in cancer: therapeutic opportunities , 2017, Oncotarget.
[19] K. Taylor,et al. Phosphorylation of zinc channel ZIP7 drives MAPK, PI3K and mTOR growth and proliferation signalling† †Electronic supplementary information (ESI) available: Supplementary figures. See DOI: 10.1039/c6mt00286b Click here for additional data file. , 2017, Metallomics : integrated biometal science.
[20] B. Fiebich,et al. Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid , 2017, Journal of Neuroinflammation.
[21] M. Faiq,et al. Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent. , 2017, Current molecular medicine.
[22] D. Kidane,et al. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage , 2016, Cell cycle.
[23] M. Othman,et al. Anaerobic Codigestion of Municipal Wastewater Treatment Plant Sludge with Food Waste: A Case Study , 2016, BioMed research international.
[24] Liangcai Zhao,et al. High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism , 2016, BioMed research international.
[25] Zachary J. Domire,et al. Basal Level of p70S6k Phosphorylation Is Higher In Aged Rats And Inversely Related To Muscle Atrophy , 2016 .
[26] N. Ahn,et al. Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation , 2016, Molecular biology of the cell.
[27] P. Maher,et al. Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence? , 2015, Front. Neurosci..
[28] Jang-Yen Wu,et al. Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases , 2015, Oxidative medicine and cellular longevity.
[29] J. Talboom,et al. The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease , 2015, npj Aging and Mechanisms of Disease.
[30] D. Butterfield,et al. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD , 2015, Journal of neurochemistry.
[31] A. Kritis,et al. Researching glutamate – induced cytotoxicity in different cell lines: a comparative/collective analysis/study , 2015, Front. Cell. Neurosci..
[32] A. Kalsbeek,et al. Impact of nutrients on circadian rhythmicity. , 2015, American journal of physiology. Regulatory, integrative and comparative physiology.
[33] Inki Kim,et al. Disparate roles of zinc in chemical hypoxia-induced neuronal death , 2015, Front. Cell. Neurosci..
[34] K. Oda,et al. mTOR Signaling in Endometrial Cancer: From a Molecular and Therapeutic Point of View , 2015, Current Obstetrics and Gynecology Reports.
[35] M. Perez-Pinzon,et al. Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics , 2015, Metabolic Brain Disease.
[36] Y. Ci,et al. ROS inhibit autophagy by downregulating ULK1 mediated by the phosphorylation of p53 in selenite-treated NB4 cells , 2014, Cell Death and Disease.
[37] D. Cameron-Smith,et al. Muscle p70S6K phosphorylation in response to soy and dairy rich meals in middle aged men with metabolic syndrome: a randomised crossover trial , 2014, Nutrition & Metabolism.
[38] D. Morris,et al. p70 Ribosomal protein S6 kinase (Rps6kb1): an update , 2014, Journal of Clinical Pathology.
[39] Xiao-dong Guo,et al. Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma , 2014, OncoTargets and therapy.
[40] J. Arthur,et al. CREB phosphorylation at Ser133 regulates transcription via distinct mechanisms downstream of cAMP and MAPK signalling. , 2014, The Biochemical journal.
[41] A. García-Sastre,et al. mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection. , 2014, Virology.
[42] K. Poutanen,et al. Disintegration of wheat aleurone structure has an impact on the bioavailability of phenolic compounds and other phytochemicals as evidenced by altered urinary metabolite profile of diet-induced obese mice , 2014, Nutrition & Metabolism.
[43] E. Verdaguer,et al. Glutamate Excitotoxicity Activates the MAPK/ERK Signaling Pathway and Induces the Survival of Rat Hippocampal Neurons In Vivo , 2014, Journal of Molecular Neuroscience.
[44] M. Ishikawa. Abnormalities in Glutamate Metabolism and Excitotoxicity in the Retinal Diseases , 2013, Scientifica.
[45] Jianping Ye,et al. Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation. , 2013, Biochimica et biophysica acta.
[46] H. Khan,et al. Neurodegeneration and Neuroprotection in Diabetic Retinopathy , 2013, International Journal of Molecular Sciences.
[47] J. Waxman,et al. Wnt/β-catenin signalling in prostate cancer , 2012, Nature Reviews Urology.
[48] C. Ip,et al. p70 S6 kinase and actin dynamics , 2012, Spermatogenesis.
[49] J. Dufour,et al. Cell lines , 2012, Spermatogenesis.
[50] B. Kasinath,et al. Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells. , 2011, AJP - Renal Physiology.
[51] Rony Seger,et al. The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. , 2010, Methods in molecular biology.
[52] J. Wands,et al. Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed , 2008, Journal of diabetes science and technology.
[53] Gordon B. Mills,et al. Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity* , 2007, Journal of Biological Chemistry.
[54] Claire L Weston,et al. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] G. Saldanha,et al. Nuclear β‐catenin in basal cell carcinoma correlates with increased proliferation , 2004, The British journal of dermatology.
[56] Chen Liu,et al. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. , 2003, American journal of clinical pathology.
[57] P. Lazarovici,et al. Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections , 2002, Science.
[58] J. Lehman,et al. Molecular crosstalk between p70S6k and MAPK cell signaling pathways. , 2002, Biochemical and biophysical research communications.
[59] E. Van Obberghen,et al. Nerve growth factor-induced phosphorylation cascade in PC12 pheochromocytoma cells. Association of S6 kinase II with the microtubule-associated protein kinase, ERK1. , 1992, The Journal of biological chemistry.